ClearPoint Neuro, Inc. Profit Breakdown
Profit breakdown shows how much each product earned: one column per product, one row per year or quarter. All amounts are the filed figures for that period.
- ClearPoint Neuro, Inc. revenue for the quarter ending 2026-06-30 was $10.88M, a 18.07% increase year-over-year.
- ClearPoint Neuro, Inc. revenue for the quarter ending 2026-03-31 was $12.13M, a 42.93% increase year-over-year.
- ClearPoint Neuro, Inc. revenue for the quarter ending 2025-12-31 was $10.41M, a 33.96% increase year-over-year.
- ClearPoint Neuro, Inc. revenue for the quarter ending 2025-09-30 was $8.86M, a 9.10% increase year-over-year.
- ClearPoint Neuro, Inc. revenue for fiscal 2025 was $36.97M, a 17.78% increase from fiscal 2024.
- ClearPoint Neuro, Inc. revenue for fiscal 2024 was $31.39M, a 31.04% increase from fiscal 2023.
- ClearPoint Neuro, Inc. revenue for fiscal 2023 was $23.96M, a 16.56% increase from fiscal 2022.
- ClearPoint Neuro, Inc. revenue for fiscal 2022 was $20.55M, a 26.09% increase from fiscal 2021.
- Available history
- 2010-12-31 to 2026-06-30
- Data captured
Profit by product
ClearPoint Neuro, Inc. did not file profit by product.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |